Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan Nami TagamiMichihiro UchiyamaShinsuke Iida Original Article Open access 29 May 2024
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications Kennosuke KarubeAkira SatouSeiichi Kato Progress in Hematology 28 May 2024
Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments Miyako KosugiRyo TakezawaKatsuya Ikuta Original Article Open access 28 May 2024
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency Shinya MatsumotoTakeshi UchiumiDongchon Kang Original Article 27 May 2024
B-cell prolymphocytic leukemia: an enduring bona fide entity Miguel S. Gonzalez-ManceraJean LopateguiSerhan Alkan Case Report 26 May 2024
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus Osamu ImatakiHaruyuki FujitaMakiko Uemura Images in Hematology 26 May 2024
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia Shota AraiTakayoshi TachibanaHideaki Nakajima Original Article 25 May 2024
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial Takanori TeshimaYasushi OnishiMakoto Onizuka Original Article Open access 25 May 2024
Novel CAR T cell therapies for patients with large B cell lymphoma Hideki GotoMasahiro OnozawaTakanori Teshima Progress in Hematology 25 May 2024
Current progress of CAR-T-cell therapy for patients with multiple myeloma Takahiro NakashimaYuki Kagoya Progress in Hematology 23 May 2024
A review of the Augustine blood group system Jing ZhongChunping MoLingbo Li Review Article 20 May 2024
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds Yoshiyuki OgawaAkitada IchinoseHiroshi Handa Case Report 18 May 2024
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia Hiroki AkiyamaHagop KantarjianKoji Sasaki Original Article 15 May 2024
Metabolic dependencies of acute myeloid leukemia stem cells Xiangguo ShiMengdie FengDaisuke Nakada Progress in Hematology 15 May 2024
Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis Yawara KawanoNao NishimuraJun-Ichirou Yasunaga Original Article 13 May 2024
A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor Lin LiuDing-song ZhangSan-bin Wang Case Report 10 May 2024
Understanding the intrinsic biology of diffuse large B-cell lymphoma: recent advances and future prospects Yusuke NaoiDaisuke Ennishi Progress in Hematology 10 May 2024
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency Wenyu ZhangJingmei LiSusumu Goyama Original Article Open access 03 May 2024
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH Dan TomomasaKay TanitaHirokazu Kanegane Original Article 03 May 2024
Protection from bleeds during physical activity in people with haemophilia: the role of factor levels: a response to Nogami et al. (2023) Olav VerslootJ. van der NetK. Fischer Letter to the Editor 01 May 2024
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia Yuta KaitoYoichi Imai Progress in Hematology 01 May 2024
Clinical features of immature leukemias in children Daichi SajikiNao YoshidaAsahito Hama Original Article 30 April 2024
Post-transfusion purpura and adult primary thrombocytopenia Philip Murphy Letter to the Editor 29 April 2024
Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA–haploidentical transplantation with high donor-specific antibodies Kengo KatsukiTakayoshi TachibanaHideaki Nakajima Case Report 27 April 2024
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment Feng-Ming TienHsin-An Hou Progress in Hematology 26 April 2024
Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia Chendong JiangShu DengEnwu Yuan Original Article Open access 26 April 2024
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma Taku KikuchiNobuhiro TsukadaTadao Ishida Original Article 19 April 2024
An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease Masataka HosoiKazunori UenoTakuro Watanabe Case Report 18 April 2024
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL) Hiroyuki Fujita Guideline 17 April 2024 Pages: 481 - 492
Bernard–Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion Rintaro NagoshiAtsushi SakamotoAkira Ishiguro Case Report 16 April 2024
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy Kenichi SakamotoOsamu MiyazakiYoko Shioda Images in Hematology 15 April 2024 Pages: 617 - 618
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review Wataru KitamuraHiroki KobayashiShoichi Kuyama Case Report 15 April 2024
Bispecific antibodies for multiple myeloma: past, present and future Toshiki OchiTatsuya KonishiKatsuto Takenaka Progress in Hematology 13 April 2024
A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom’s macroglobulinemia Koji IzutsuHisashi KatoEi Fujikawa Original Article Open access 10 April 2024
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas Sha ZhouJun RaoLi Gao Original Article Open access 08 April 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group Noriyoshi IriyamaEisaku IwanagaTatsuya Kawaguchi Original Article 08 April 2024
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid Yusuke InoueAsuka OdaMasahiro Abe Rapid Communication 06 April 2024 Pages: 626 - 630
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era Yumiko TodaMasahiro AshizawaYoshinobu Kanda Original Article 05 April 2024 Pages: 660 - 666
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma Naoko EnzanAkihiro KitadateMichihiro Kono Review Article Open access 02 April 2024 Pages: 619 - 625
Clinical guidelines for prevention and treatment of CAT in Japan and other countries Yoshinobu Seki Progress in Hematology 01 April 2024 Pages: 505 - 515
Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts Makoto ItoNobuaki Fukushima Images in Hematology 30 March 2024 Pages: 476 - 478
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021) Hirohiko ShibayamaMitsuhiro ItagakiShinsuke Iida Original Article Open access 29 March 2024 Pages: 707 - 721
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain Hirono IriuchishimaAkio SaitoMorio Matsumoto Original Article 29 March 2024
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease Lu ZhangYu-han GaoJian Li Original Article 28 March 2024 Pages: 631 - 637
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis Mary Jo LechowiczChristy SmithKaren Dwyer Original Article Open access 27 March 2024 Pages: 736 - 744
Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival Yoshihiro Fujimura Review Article 27 March 2024 Pages: 532 - 540
Recent advances in understanding the biology of follicular lymphoma Momoko Nishikori Progress in Hematology 27 March 2024
Rapamycin increases leukemia cell sensitivity to chemotherapy by regulating mTORC1 pathway-mediated apoptosis and autophagy Jing XuSiwen ZongZhenjiang Li Original Article 26 March 2024 Pages: 541 - 551
